[at Motley Fool] – Big subsidies could help Humana, WellPoint, and UnitedHealth get more people to get insurance, and thereby save HCA, Tenet Healthcare, and other hospital operators money from uninsured losses.
Read more on this.
UnitedHealth Group Incorporated (UNH), with a current value of $72.72B, started the session at $71.35.
A quick look at the market, the company’s traded between $71.01 to $71.58 with a one year range of $51.09 to $75.88.
Priced at 13.12x this year’s forecasted earnings,
UNH shares are relatively inexpensive compared to the industry’s 16.83x forward p/e ratio.
And for those looking to make a return holding the stock, the company pays shareholders $1.12 per share annually in dividends, yielding 1.60% .
According to a consensus of 21 analysts, the earnings estimate of $1.52 per share would be $0.02 better than the year-ago quarter but a $0.01 sequential decrease. The full-year EPS estimate is $5.50 which would be $0.22 better than last year’s full-year earnings.
The quarterly earnings estimate is predicated on a consensus revenue forecast of $30.79 Billion. If reported, that would be a 12.78% increase over the year-ago quarter.
More recently, Standpoint Research downgraded (UNH) from Buy to Hold (Jun 17, 2013).
Previously, Oppenheimer upgraded (UNH) from Perform to Outperform. Oppenheimer upgraded (UNH) from Underperform to Perform.
When considering if the stock is under or overvalued, the average price target is $78.30, which is 9.74% above where the stock opened this morning.
UnitedHealth Group Incorporated (NYSE:UNH), operates as a diversified health and well-being company in the United States. The companys UnitedHealthcare segment offers
consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses and individuals.
Tag Helper ~ Stock Code: UNH | Common Company name: UnitedHealth | Full Company name: UnitedHealth Group Incorporated (NYSE:UNH) .